182 related articles for article (PubMed ID: 8427828)
1. A case of xeroderma pigmentosum complementation group F with neurological abnormalities.
Moriwaki S; Nishigori C; Imamura S; Yagi T; Takahashi C; Fujimoto N; Takebe H
Br J Dermatol; 1993 Jan; 128(1):91-4. PubMed ID: 8427828
[TBL] [Abstract][Full Text] [Related]
2. Sensitivity to UV radiation of fibroblasts from a Japanese group A xeroderma pigmentosum patient with mild neurological abnormalities.
Sato K; Watatani M; Ikenaga M; Kozuka T; Kitano Y; Yoshikawa K; Mimaki T; Abe J; Sugita T
Br J Dermatol; 1987 Jan; 116(1):101-8. PubMed ID: 3814505
[TBL] [Abstract][Full Text] [Related]
3. Xeroderma pigmentosum complementation group E: a case report.
Kawada A; Satoh Y; Fujiwara Y
Photodermatol; 1986 Aug; 3(4):233-8. PubMed ID: 3774595
[TBL] [Abstract][Full Text] [Related]
4. Xeroderma pigmentosum group D patient bearing lentigo maligna without neurological symptoms.
Fukuro S; Yamaguchi J; Mamada A; Kondo S; Satoh Y
Dermatologica; 1990; 181(2):129-33. PubMed ID: 2242781
[TBL] [Abstract][Full Text] [Related]
5. Clinical and photobiological characteristics of xeroderma pigmentosum complementation group F: a review of cases from Japan.
Yamamura K; Ichihashi M; Hiramoto T; Ogoshi M; Nishioka K; Fujiwara Y
Br J Dermatol; 1989 Oct; 121(4):471-80. PubMed ID: 2696553
[TBL] [Abstract][Full Text] [Related]
6. Xeroderma pigmentosum patients belonging to complementation group F and efficient liquid-holding recovery of ultraviolet damage.
Nishigori C; Fujisawa H; Uyeno K; Kawaguchi T; Takebe H
Photodermatol Photoimmunol Photomed; 1991 Aug; 8(4):146-50. PubMed ID: 1814424
[TBL] [Abstract][Full Text] [Related]
7. A seventh complementation group in excision-deficient xeroderma pigmentosum.
Keijzer W; Jaspers NG; Abrahams PJ; Taylor AM; Arlett CF; Zelle B; Takebe H; Kinmont PD; Bootsma D
Mutat Res; 1979 Aug; 62(1):183-90. PubMed ID: 492197
[TBL] [Abstract][Full Text] [Related]
8. Assignment of six patients with xeroderma pigmentosum in Hokkaido area to a variant form.
Fujikawa K; Ayaki H; Ishizaki K; Takatera H; Matsuo S; Iizuka H; Koizumi H; Ikenaga M
J Radiat Res; 1994 Sep; 35(3):168-78. PubMed ID: 7830260
[TBL] [Abstract][Full Text] [Related]
9. No apparent neurologic defect in a patient with xeroderma pigmentosum complementation group D.
Ichihashi M; Yamamura K; Hiramoto T; Fujiwara Y
Arch Dermatol; 1988 Feb; 124(2):256-60. PubMed ID: 3341805
[TBL] [Abstract][Full Text] [Related]
10. Clinical symptoms and DNA repair characteristics of xeroderma pigmentosum patients from Germany.
Thielmann HW; Popanda O; Edler L; Jung EG
Cancer Res; 1991 Jul; 51(13):3456-70. PubMed ID: 2054785
[TBL] [Abstract][Full Text] [Related]
11. Xeroderma pigmentosum neurological abnormalities correlate with colony-forming ability after ultraviolet radiation.
Andrews AD; Barrett SF; Robbins JH
Proc Natl Acad Sci U S A; 1978 Apr; 75(4):1984-8. PubMed ID: 273925
[TBL] [Abstract][Full Text] [Related]
12. A ninth complementation group in xeroderma pigmentosum, XP I.
Fischer E; Keijzer W; Thielmann HW; Popanda O; Bohnert E; Edler L; Jung EG; Bootsma D
Mutat Res; 1985 May; 145(3):217-25. PubMed ID: 3982437
[TBL] [Abstract][Full Text] [Related]
13. Xeroderma pigmentosum complementation group G--report of two cases.
Norris PG; Hawk JL; Avery JA; Giannelli F
Br J Dermatol; 1987 Jun; 116(6):861-6. PubMed ID: 3620347
[TBL] [Abstract][Full Text] [Related]
14. Clinical, cellular, and molecular features of an Israeli xeroderma pigmentosum family with a frameshift mutation in the XPC gene: sun protection prolongs life.
Slor H; Batko S; Khan SG; Sobe T; Emmert S; Khadavi A; Frumkin A; Busch DB; Albert RB; Kraemer KH
J Invest Dermatol; 2000 Dec; 115(6):974-80. PubMed ID: 11121128
[TBL] [Abstract][Full Text] [Related]
15. A lack of radiation-induced ornithine decarboxylase activity prevents enhanced reactivation of herpes simplex virus and is linked to non-cancer proneness in xeroderma pigmentosum patients.
Terleth C; van Laar T; Schouten R; van Steeg H; Hodemaekers H; Wormhoudt T; Cornelissen-Steijger PD; Abrahams PJ; van der Eb AJ
Cancer Res; 1997 Oct; 57(19):4384-92. PubMed ID: 9331102
[TBL] [Abstract][Full Text] [Related]
16. Sodium butyrate stimulates cellular recovery from UV damage in xeroderma pigmentosum cells belonging to complementation group F.
Nishigori C; Takebe H
Jpn J Cancer Res; 1987 Sep; 78(9):932-6. PubMed ID: 3117749
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of eight groups of xeroderma pigmentosum by genetic complementation using recombinant adenovirus vectors.
Yamashita T; Okura M; Ishii-Osai Y; Hida T
J Dermatol; 2016 Oct; 43(10):1167-1173. PubMed ID: 26971583
[TBL] [Abstract][Full Text] [Related]
18. Xeroderma pigmentosum complementation group F in a non-Japanese patient.
Norris PG; Hawk JL; Avery JA; Giannelli F
J Am Acad Dermatol; 1988 May; 18(5 Pt 2):1185-8. PubMed ID: 3372781
[TBL] [Abstract][Full Text] [Related]
19. Clinical, genetic and DNA repair studies on a consecutive series of patients with xeroderma pigmentosum.
Pawsey SA; Magnus IA; Ramsay CA; Benson PF; Giannelli F
Q J Med; 1979 Apr; 48(190):179-210. PubMed ID: 504548
[TBL] [Abstract][Full Text] [Related]
20. A DNA repair defect in a patient with ataxia, mental retardation, and short stature.
Yamagata T; Momoi MY; Saitoh S; Takadaya K; Sato K
Pediatr Neurol; 1998 Apr; 18(4):358-61. PubMed ID: 9588536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
